These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3480598)

  • 1. [F-dimers in the diagnosis and therapy of deep leg venous thrombosis].
    Seyfert UT; Schneider T; Hauck W; Ott C
    Vasa Suppl; 1987; 20():240-3. PubMed ID: 3480598
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experiences with streptokinase and urokinase therapy of different dosages in deep venous thrombosis].
    Trübestein G; Trübestein R; Ludwig M; Wilgalis M; Christ F
    Vasa Suppl; 1987; 20():161-4. PubMed ID: 3480594
    [No Abstract]   [Full Text] [Related]  

  • 3. [Late results following fibrinolysis therapy of venous thromboses].
    Breddin HK
    Internist (Berl); 1984 Feb; 25(2):102-7. PubMed ID: 6368451
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative study of the morphologic behavior of fresh leg and pelvic vein thromboses treated with streptokinase, urokinase and heparin based on phlebography follow-up].
    Christ F; Bohlmann C; Ludwig M; Trübestein G
    Vasa Suppl; 1989; 27():115-6. PubMed ID: 2516365
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on thrombolytic therapy for venous thrombosis in the extremities--dynamics of plasmin inhibitor and FDP following administration of urokinase (author's transl)].
    Takeuchi S; Shiba T
    Nihon Geka Hokan; 1979 May; 48(3):354-61. PubMed ID: 157109
    [No Abstract]   [Full Text] [Related]  

  • 6. Modifications in coagulation parameters induced by treatment associating urokinase (2000 u CTA/kg/h) with heparin.
    Juhan I; Calas MF; Buonocore M; Mathieu P; Isnard G; Cazenave B; Serradimigni A
    Thromb Haemost; 1979 Oct; 42(3):945-54. PubMed ID: 315625
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diagnosis and therapy of deep phlebothrombosis of the extremities].
    Mörl H
    Z Gesamte Inn Med; 1991 Oct; 46(15):586-90. PubMed ID: 1771930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fibrinolytic treatment of deep venous thromboses with streptokinase at an ultrahigh dosage].
    Theiss W; Baumann G; Klein G
    Dtsch Med Wochenschr; 1987 Apr; 112(17):668-74. PubMed ID: 3569060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep vein thrombosis: diagnosis, treatment, and prevention.
    Stewart WP; Youngswick FD
    J Foot Surg; 1981; 20(4):232-8. PubMed ID: 7033339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic fibrinolytic activity and inhibitor levels during treatment of deep vein thrombosis with urokinase and streptokinase.
    Theiss W; Asbeck F; Kriessmann A; Trübestein G; Knoch K; de Swart CA; Marbert GA; van de Loo JC
    Thromb Haemost; 1983 Oct; 50(3):664-8. PubMed ID: 6196852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fibrin and fibrinogen degradation products in suspected deep venous thrombosis of the lower extremities].
    Sørensen MD; Ott P; Gad I; Gyhrs S; Iversen D; Treufeldt P
    Ugeskr Laeger; 1988 Jan; 150(1):20-2. PubMed ID: 3376204
    [No Abstract]   [Full Text] [Related]  

  • 12. Thrombolytic effect of streptokinase as evaluated by phlebography of deep venous thrombi of the leg.
    Robertson BR; Nilsson IM; Nylander G
    Acta Chir Scand; 1970; 136(3):173-80. PubMed ID: 5518308
    [No Abstract]   [Full Text] [Related]  

  • 13. Markers of hemostatic system activation in acute deep venous thrombosis-evolution during the first days of heparin treatment. The DVTENOX Study Group.
    Thromb Haemost; 1993 Dec; 70(6):909-14. PubMed ID: 8165610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated plasma levels of fibrin degradation products by granulocyte-derived elastase in patients with deep vein thrombosis.
    Kamikura Y; Wada H; Nobori T; Matsumoto T; Shiku H; Ishikura K; Yamada N; Nakano T; Kazahaya Y; Sawai T; Matsuda M
    Thromb Res; 2005; 115(1-2):53-7. PubMed ID: 15567453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Peripheral local lysis in deep leg and pelvic vein thrombosis. A new, additional treatment possibility--results of 29 patients].
    Meyer J
    Vasa Suppl; 1991; 32():309-13. PubMed ID: 1771521
    [No Abstract]   [Full Text] [Related]  

  • 16. Causes and diagnosis of deep vein thrombosis.
    van der Linden W; von Schéele C; Kempi V
    Compr Ther; 1976 Aug; 2(8):10-7. PubMed ID: 954385
    [No Abstract]   [Full Text] [Related]  

  • 17. Can the results of treatment of deep venous thrombosis be improved by combining surgical thrombectomy with regional fibrinolysis?
    Nachbur BB; Beck EA; Senn A
    J Cardiovasc Surg (Torino); 1980; 21(3):347-52. PubMed ID: 6993494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled multicenter pilot study of urokinase- heparin and streptokinase in deep vein thrombosis.
    van de Loo JC; Kriessmann A; Trübestein G; Knoch K; de Swart CA; Asbeck F; Marbet GA; Schmitt HE; Sewell AF; Duckert F
    Thromb Haemost; 1983 Oct; 50(3):660-3. PubMed ID: 6359570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fibrinolytic therapy of deep vein thrombosis of the leg and pelvis with streptokinase and urokinase].
    Hasler K; Neumann H
    Med Welt; 1983 Oct; 34(43):1225-9. PubMed ID: 6645913
    [No Abstract]   [Full Text] [Related]  

  • 20. Thrombolytic therapy for deep vein thrombosis.
    Persson AV; Persson CA
    Am J Surg; 1985 Oct; 150(4A):50-3. PubMed ID: 4051121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.